Company intelligence / Profile preview

Pine Pharmaceuticals

Tonawanda, NY, United Statespinepharmaceuticals.com ↗

Ownership: Private
Development stage: Other

Overview

Pine Pharmaceuticals operates one of the largest FDA‑registered Section 503B outsourcing facilities in the U.S., providing high-quality sterile and non‑sterile compounded and repackaged drug products to hospitals and surgery centers nationwide. The company has expanded its portfolio through acquisition of Athenex’s outsourcing business. It supplies critical care medications such as phenylephrine, epinephrine, vasopressin, and diltiazem injections to address drug shortages across healthcare systems.

Therapeutic areas: Cardiovascular
Modalities: Small moleculeBiologicProteinPeptide
Industry: Contract Manufacturing Organization

Partnerships

Acquired Athenex’s outsourcing business/assets in May 2023partners with hospitals nationwide for supply continuity

Beyond the preview

Go deeper on Pine Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pine Pharmaceuticals.

Explore the full profile